The Human microbiome /
Μορφή: | Ηλ. βιβλίο |
---|---|
Γλώσσα: | English |
Έκδοση: |
London :
Academic Press,
[2017].
|
Σειρά: | Methods in microbiology ;
v. 44. |
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- ""Front Cover""; ""The Human Microbiome""; ""Copyright""; ""Contents""; ""Contributors""; ""Preface""; ""Chapter 1: Bioinformatics in Microbiome Analysis""; ""1. Introduction""; ""2. Bioinformatic Applications for the Analysis of Single Pathogens""; ""3. Bioinformatic Applications for the Analysis of Microbial Communities""; ""3.1. 16S rRNA-Based Approach and Taxonomic Diversity""; ""3.2. Metagenomic Shotgun Sequencing Approach""; ""4. Statistics, Machine Learning and Network Analysis""; ""5. Sequencing Platforms""; ""6. Future Prospective""; ""References""; ""Further Reading""
- ""Chapter 2: A Review of the Oesophageal Microbiome in Health and Disease""""1. Introduction""; ""1.1. Oesophageal Microbiome Composition""; ""1.2. Oesophageal Microbiome Variation Between Individuals""; ""2. Functions of the Oesophageal Microbiome""; ""2.1. Barrier Functions of the Microbiome""; ""2.2. Metabolic Functions of the Microbiome""; ""2.3. Immunomodulation by the Microbiome""; ""2.4. Effects of Gut Microbiome on Host Beyond the Intestinal Tract""; ""3. Oesophageal Microbiome and Disease""; ""3.1. Oesophageal Microbiome and Reflux Disease and Barrett's Oesophagus""
- ""3.2. Oesophageal Microbiome and Cancer""""3.2.1. Microbiome toxin production and cancer""; ""3.2.2. Metabolism and cancer development""; ""3.2.3. Mucin production and cancer""; ""3.2.4. Bystander effect""; ""3.2.5. Role of viruses and oesophageal cancer""; ""4. Future Directions""; ""4.1. Study Design""; ""4.2. ""Omics"" Technologies""; ""4.3. Metagenomics""; ""4.4. Metatranscriptomics""; ""4.5. Metaproteomics and Metabolomics""; ""Conclusion""; ""Acknowledgements""; ""References""
- ""Chapter 3: The Application of Molecular Methods Towards an Understanding of the Role of the Vaginal Microbiome in Health ...""""1. Introduction""; ""2. Lactobacillus-Mediated Protection""; ""2.1. Lactobacillus spp. of the Vaginal Microbiome""; ""2.1.1. Adhesion and competitive exclusion""; ""2.1.2. Lactic acid""; ""2.1.3. Bacteriocins""; ""2.1.4. Hydrogen peroxide""; ""2.1.5. Immune modulation""; ""3. The Vaginal Microbiome""; ""3.1. Community State Types""; ""3.2. CST-I: L. crispatus-Dominated Microbiota""; ""3.3. CST-III: L. iners-Dominated Microbiota""
- ""3.4. CST-II: L. gasseri- and CST-V: L. jensenii-Dominated Microbiota""""3.5. CST-IV: Lactobacillus-Depauperate Microbiomes""; ""4. Modulators of the Vaginal Microbiome""; ""4.1. Age and Physiology""; ""4.1.1. Newborn to infancy""; ""4.1.2. Childhood""; ""4.1.3. Adolescence""; ""4.1.4. Reproductive-aged women""; ""4.1.5. Postmenopausal women""; ""4.2. Menses""; ""4.3. Pregnancy""; ""4.4. Host Behaviours""; ""4.5. Sexual Activity""; ""5. Vaginal Dysbiosis and Morbidity""; ""Summary and Conclusions""; ""References""; ""Further Reading""